AdaptHealth Corp
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
AHCO$7.72+5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations—For the years ended and
(in thousands, except per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net revenue | $3,200,177 | $2,970,595 | $2,454,535 |
| Grant income | — | — | 10,595 |
| Costs and expenses: | |||
| Cost of net revenue | 2,720,613 | 2,553,169 | 2,008,925 |
| General and administrative expenses | 190,091 | 162,125 | 167,505 |
| Depreciation and amortization, excluding patient equipment depreciation | 57,087 | 64,890 | 63,095 |
| Goodwill impairment (note 5) | 830,787 | — | — |
| Total costs and expenses | 3,798,578 | 2,780,184 | 2,239,525 |
| Operating (loss) income | (598,401) | 190,411 | 225,605 |
| Interest expense, net | 130,299 | 109,414 | 95,195 |
| Change in fair value of warrant liability (note 11) | (34,482) | (17,158) | (53,181) |
| Change in fair value of contingent consideration common shares liability (note 11) | — | — | (29,389) |
| Loss on extinguishment of debt | — | — | 20,189 |
| Other loss, net | 29,566 | 253 | 1,832 |
| (Loss) income before income taxes | (723,784) | 97,902 | 190,959 |
| Income tax (benefit) expense | (49,004) | 24,769 | 32,806 |
| Net (loss) income | (674,780) | 73,133 | 158,153 |
| Income attributable to noncontrolling interest | 4,115 | 3,817 | 1,978 |
| Net (loss) income attributable to AdaptHealth Corp. | $(678,895) | $69,316 | $156,175 |
| Weighted average common shares outstanding - basic | 134,156 | 134,175 | 126,306 |
| Weighted average common shares outstanding - diluted | 134,418 | 138,988 | 133,034 |
| Basic net (loss) income per share (note 12) | $(5.06) | $0.47 | $1.12 |
| Diluted net (loss) income per share (note 12) | $(5.31) | $0.33 | $0.67 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.